[{"Assets_0_Q3_USD":640530000.0,"CIK":"1743881","CommonStockSharesConverted_0_Q3_shares":117359502.0,"CommonStockSharesOutstanding_0_Q3_shares":117359502.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.51,"EarningsPerShareBasic_3_Q3_USD":-1.86,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-177384000.0,"NetIncomeLossConverted_1_Q3_USD":-59980000.0,"NetIncomeLossConverted_3_Q3_USD":-187129000.0,"OfficialName":"BridgeBio Pharma Inc. Common Stock","RevenuesConverted_1_Q3_USD":26741000.0,"RevenuesConverted_3_Q3_USD":26741000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":521697000.0,"StockholdersEquity_0_Q3_USD":459758000.0,"Ticker":"BBIO","filed":"20191108","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"BRIDGEBIO PHARMA, INC.","period":"20190930","qtrs":"0","uom":"USD"}]